Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-679-6 | CAS number: 124-09-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Study period:
- no data
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- other: Old study (1947), no guideline. Protocol different from standard method even if few method details were reported. HMD tested as aqueous solution at 2% and 1%
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 947
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- The aim of this study was to analysed the skin sensitisation potential of Hexamethylene Diamine (HMD) at 2% and 1%. Experiment was realised with 10 Guinea Pig.
A 2% HMD aqueous solution was applicated (Epicutaneous route) of clipped Guinea Pig.Three successive applications were performed the first day on the same area . Then, six successive subcutaneous injections of solution of 1% HMD were performed on the left side through 13 days followed by a 8-day rest period.Then a final patch application was performed as the beginning with 1% and 2% HMD aqueous solution. Skin lesions were recorded after patch removal. Finally, a seventh final test substance subcutaneous injection was administered to the animals.
Finally Guinea Pigs were sacrified with Illum gas two days after final injection and a gross-autopsy was performed for some animals.
Skin reactions were analysed and weight measured for approximatively one month through both treatment period. - GLP compliance:
- no
- Remarks:
- Study performed before GLP establishment
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- Hexamethylenediamine
- EC Number:
- 204-679-6
- EC Name:
- Hexamethylenediamine
- Cas Number:
- 124-09-4
- Molecular formula:
- C6H16N2
- IUPAC Name:
- hexane-1,6-diamine
- Details on test material:
- - Name of test material (as cited in study report): Hexamethylene Diamine at 2% and 1%
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals and environmental conditions:
- No data
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- Induction: aqueous solution of 2% hexamethylene diamine (epicutaneous route) and 1% (intradermal route)
Challenge: aqueous solution of 2% hexamethylene diamine (epicutaneous route) and 1% (intradermal route)
Challengeopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- Induction: aqueous solution of 2% hexamethylene diamine (epicutaneous route) and 1% (intradermal route)
Challenge: aqueous solution of 2% hexamethylene diamine (epicutaneous route) and 1% (intradermal route)
- No. of animals per dose:
- 10
- Details on study design:
- No additional data
- Challenge controls:
- No data
- Positive control substance(s):
- no
Study design: in vivo (LLNA)
- Statistics:
- No data
Results and discussion
- Positive control results:
- No data
Any other information on results incl. tables
Table 7.2.1 : Weight evolution of Guinea Pigs after both treatments
Time after treatment started |
#G.Pig |
# treatment |
% gain or loss in weight |
0 hours |
10 |
Initial Patch |
- |
Wed ¿ 16-29-47 Subcu. Inj. started |
|||
72 hours |
10 |
1 |
+4.77% |
6 days |
10 |
3 |
+5.20% |
10 days |
10 |
5 |
+6.73% |
13 days |
10 |
6 |
+4.05% |
11-11 to 11-19 inc. Rest Period |
|||
17 days |
10 |
Rest period |
+6.63% |
20 days |
10 |
Rest period |
+3.70% |
Thurs 11-20 Final Patch |
|||
24 days |
10 |
Final Patch |
+0.55% |
27 days |
10 |
Final sub-inj. |
+6.83% |
28 days |
10 |
Final sub-inj. |
-2.29% |
29 days |
10 |
Final sub-inj. |
+0.39% |
Applicant's summary and conclusion
- Interpretation of results:
- other: no sensitisation after final patch application
- Conclusions:
- Under the test conditions, no skin sensitisation was observed in any animals after final patch application. Necrosis was observed 24-hour after the last injections following the final patch application.
- Executive summary:
The skin sensitisation potential of Hexamethylene Diamine (HMD) at 2% and 1% was tested (Hardy, 1947b). Experiment was realized with 10 Guinea Pig.
A 2% HMD aqueous solution was applicated (epicutaneous route) on back (near shoulder) of clipped Guinea Pig.Three successive applications were performed the first day on the same area . Then, six successive subcutaneous injections of solution of 1% HMD were performed on the left side through 13 days followed by a 8-day rest period. Then the challenge (epicutaneous and intradermal routes) was performed with 2% and 1% HMD aqueous solution. Skin reactions were analysed. Finally Guinea Pigs were sacrified with Illum gas two days after final injection (challenge) and a gross-autopsy was performed for some animals. The body weight gain was measured.
Animals showed necrotic area at site of injection of HMD 3 days after treatment. Swelling occured at site of injection at 6 days post treatment. Gross-autopsy was performed for three Guinea Pig.
Skin between shoulders appear normal. Site of last injection marked by area of hemmorhage and necrosis, first and second red area on overlying skin surface. Internal organs grossly normal.After initial patch application, within ten minutes, G. Pigs began hopping around cage definite erythema on left side. One hour after application, HMD showed signs of becoming necrotic + dark brown. Three hours post application, application site was definitely necrotic dark brown. At the end of the experiment, necrotic areas beginning to slough off slightly.
Under the test conditions, necrosis was observed 24-hour after the last injections following the final patch application. Based on these results, no conclusion can be made.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.